Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Filamin C pseudogene (ENSG00000224163, LOC392787) is a non-protein-coding genomic sequence highly homologous (>98%) to the terminal exons (46, 47, 48) and adjacent introns of the functional FLNC gene, which encodes filamin C, an actin-binding protein essential for cardiac and skeletal muscle function[2][8]. The pseudogene does not produce a functional filamin C protein and is not known to participate in actin crosslinking or muscle cytoskeleton integrity. Misidentification or inadvertent inclusion of the pseudogene in genetic studies can lead to erroneous conclusions regarding disease causation; careful molecular methods are required to distinguish between mutations in FLNC and its pseudogene[2][8]. ENSG00000224163 (LOC392787) is a filamin C pseudogene, not a receptor or actionable molecular target. It does not encode a protein and is not implicated in human disease or drug action. Its main relevance is technical: distinction from the functional FLNC gene is necessary in genetic diagnostics[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Filamin C pseudogene.